CEMEX, S.A.B. de C.V. (CX)

Lumos Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,166	864	624	495	613	950
Cash & Short-Term Investments	1,166	864	624	495	613	950
Cash Growth	173.96%	38.46%	26.06%	-19.25%	-35.47%	20.56%
Accounts Receivable	1,919	1,582	1,751	1,644	1,521	1,533
Other Receivables	690.26	143	156	160	115	156
Receivables	2,609	1,739	1,923	1,819	1,647	1,699
Inventory	1,620	1,485	1,789	1,669	1,261	971
Other Current Assets	265.17	928	669	543	704	615
Total Current Assets	5,659	5,016	5,005	4,526	4,225	4,235
Property, Plant & Equipment	11,913	11,240	12,466	11,284	11,322	11,413
Long-Term Investments	783.01	758	733	648	552	536
Goodwill	7,566	7,441	7,674	7,538	7,984	8,506
Other Intangible Assets	1,996	1,920	1,856	1,755	1,779	1,746
Long-Term Deferred Tax Assets	646.63	673	363	411	562	740
Other Long-Term Assets	238.01	251	336	285	226	249
Total Assets	28,802	27,299	28,433	26,447	26,650	27,425
Accounts Payable	2,960	3,090	3,109	2,966	2,762	2,571
Accrued Expenses	319.15	114	88	96	99	105
Short-Term Debt	640.28	167	15	49	5	74
Current Portion of Long-Term Debt	-	680	688	680	670	691
Current Portion of Leases	278.14	269	272	258	265	293
Current Income Taxes Payable	455.12	469	1,082	368	437	445
Current Unearned Revenue	-	269	384	293	257	201
Other Current Liabilities	1,944	1,034	1,148	836	885	972
Total Current Liabilities	6,597	6,092	6,786	5,546	5,380	5,352
Long-Term Debt	5,102	5,340	6,203	6,920	7,336	9,204
Long-Term Leases	901.24	902	986	918	911	967
Long-Term Unearned Revenue	-	17	22	27	32	42
Long-Term Deferred Tax Liabilities	547.97	548	443	394	485	658
Other Long-Term Liabilities	1,411	1,364	1,142	1,038	1,236	911
Total Liabilities	15,145	14,822	16,317	15,538	16,379	18,473
Common Stock	318.13	318	318	318	318	318
Additional Paid-In Capital	7,381	7,381	7,381	7,492	7,492	7,575
Retained Earnings	6,169	5,247	4,428	4,246	3,388	2,635
Treasury Stock	-	-	-	-111	-14	-94
Comprehensive Income & Other	-507.32	-770	-363	-1,444	-1,357	-2,359
Total Common Equity	13,361	12,176	11,764	10,501	9,827	8,075
Minority Interest	296.85	301	352	408	444	877
Shareholders' Equity	13,657	12,477	12,116	10,909	10,271	8,952
Total Liabilities & Equity	28,802	27,299	28,433	26,447	26,650	27,425
Total Debt	6,921	7,358	8,164	8,825	9,187	11,229
Net Cash (Debt)	-5,756	-6,494	-7,540	-8,330	-8,574	-10,279
Net Cash Per Share	-0.39	-0.44	-0.51	-0.56	-0.57	-0.70
Filing Date Shares Outstanding	14,508	14,488	14,488	14,488	14,708	14,708
Total Common Shares Outstanding	14,508	14,488	14,488	14,488	14,708	14,708
Working Capital	-937.55	-1,076	-1,781	-1,020	-1,155	-1,117
Book Value Per Share	0.92	0.70	0.67	0.66	0.60	0.55
Tangible Book Value	3,798	2,815	2,234	1,208	64	-2,177
Tangible Book Value Per Share	0.26	0.06	0.02	0.01	-0.06	-0.15
Land	-	5,120	5,295	4,843	4,801	4,741
Buildings	-	2,426	2,636	2,342	2,532	2,438
Machinery	-	11,962	12,702	11,663	11,727	11,929
Construction In Progress	-	1,398	1,931	1,668	1,262	1,188

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q